{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:36:05Z","timestamp":1783362965974,"version":"3.54.6"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Distinguishing desmoplastic melanomas (DMs) from neurofibromas (NFs) can be histologically challenging in some cases. To date, a reliable marker to differentiate the 2 entities has remained elusive. S100 subtyping and CD34 fingerprinting have been proposed, but controversy remains as to their reliability. Missense mutations in TP53 are often found in DMs, resulting in a dominant negative effect and paradoxical accumulation of the tumor suppressor protein p53. We hypothesized that p53 may be expressed differentially in DMs, making it a valuable tool in differentiating DMs from NFs. Using immunohistochemistry, we compared p53 protein expression in 20 DMs and 20 NFs retrieved from our tissue archives and stained with p53 antibody (Monoclonal, DO-7). Patients with DM included 18 men and 2 women (age, 36 to 95\u2009y; mean, 70.5\u2009y; median, 70\u2009y). Fifteen (15\/20) tumors occurred in head and neck area; 2 (2\/20) on the trunk; and 3 (3\/20) on the extremities. Patients with NF included 12 men and 8 women (age, 47 to 85\u2009y; mean, 65.2\u2009y; median, 69.5\u2009y). Eleven (11\/20) tumors occurred on the trunk, 6 (6\/20) on the extremities, and 3 (3\/20) on the head and neck area. A total of 19\/20 (95%) DMs were positive for p53. DM Histo-scores ranged from 0 to 300 (mean, 203; median, 260). Nuclear accumulation of p53 was seen in all 19 positive DMs. None of the 20 NFs were positive for p53 (2-tailed <jats:italic toggle=\"yes\">t<\/jats:italic> test <jats:italic toggle=\"yes\">P<\/jats:italic>-value &lt;0.0001). Detection of p53 by immunohistochemistry can help to distinguish DMs from NFs. <\/jats:p>","DOI":"10.1097\/pas.0000000000000978","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T21:15:29Z","timestamp":1510780529000},"page":"372-375","source":"Crossref","is-referenced-by-count":24,"title":["Distinguishing Neurofibroma From Desmoplastic Melanoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Ashley","family":"Elsensohn","sequence":"first","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shiu","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narina","family":"Grove","sequence":"additional","affiliation":[{"name":"Pathology, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marie","family":"Hosking","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Barr","sequence":"additional","affiliation":[{"name":"Laguna Pathology Medical Group, Laguna Hills, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"de Feraudy","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO;2-E","article-title":"Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma)","volume":"28","author":"Conley","year":"1971","journal-title":"Cancer"},{"key":"R3-20240215","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/cup.12206","article-title":"Fingerprint CD34 immunopositivity to distinguish neurofibroma from an early\/paucicellular desmoplastic melanoma can be misleading","volume":"40","author":"Husain","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R4-20240215","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1600-0560.2007.00953.x","article-title":"Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors","volume":"35","author":"Nonaka","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R5-20240215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1600-0560.2011.01700.x","article-title":"Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint","volume":"38","author":"Yeh","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R6-20240215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000478-200102000-00007","article-title":"Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma","volume":"25","author":"Busam","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R7-20240215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1600-0560.2010.01568.x","article-title":"SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar","volume":"37","author":"Ramos-Herberth","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R8-20240215","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.20861","article-title":"Absence of V599E BRAF mutations in desmoplastic melanomas","volume":"103","author":"Davison","year":"2005","journal-title":"Cancer"},{"key":"R9-20240215","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0000000000000451","article-title":"NF1 mutations are common in desmoplastic melanoma","volume":"39","author":"Wiesner","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R10-20240215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s004390000374","article-title":"Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma","volume":"107","author":"Gutzmer","year":"2000","journal-title":"Hum Genet"},{"key":"R11-20240215","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/PAS.0000000000000201","article-title":"Desmoplastic melanoma with sarcomatoid dedifferentiation","volume":"38","author":"Kiuru","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R12-20240215","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"key":"R13-20240215","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J Clin Oncol"},{"key":"R14-20240215","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/onc.2009.197","article-title":"Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors","volume":"28","author":"John","year":"2009","journal-title":"Oncogene"},{"key":"R15-20240215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1995.tb02487.x","article-title":"Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications","volume":"133","author":"Weiss","year":"1995","journal-title":"Br J Dermatol"},{"key":"R16-20240215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/cdd.2009.173","article-title":"Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-\u03b13 binding","volume":"17","author":"Marchenko","year":"2010","journal-title":"Cell Death Differ"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:09:20Z","timestamp":1707980960000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00013"}},"subtitle":["The Value of p53"],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000978","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}